首页 | 本学科首页   官方微博 | 高级检索  
检索        


A Clinical Phase II Study to Assess Efficacy,Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease
Institution:1. Eye Research Foundation, Newport Beach, California;2. Andover Eye Associates, Andover, Massachusetts;3. MedRACS Clinical Research, LLC, Quincy, Massachusetts;4. Central Maine Eye Care, Lewiston, Maine;5. Massachusetts Eye and Ear Infirmary / Harvard Medical School, Boston, Massachusetts;6. BAST Modelling & Simulation Consultancy Service, Heidelberg, Germany;7. Clinical and Regulatory Affairs Consultancy Services (CaRACS), Berlin, Germany;8. Ora Inc, Andover, Massachusetts;9. Department of Ophthalmology, Medical Faculty, University of Cologne, Cologne, Germany;10. Novaliq GmbH, Heidelberg, Germany
Abstract:
Keywords:AE"}  {"#name":"keyword"  "$":{"id":"kwrd0015"}  "$$":[{"#name":"text"  "_":"adverse event  CFS"}  {"#name":"keyword"  "$":{"id":"kwrd0025"}  "$$":[{"#name":"text"  "_":"corneal fluorescein staining  CI"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"confidence interval  CsA"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"cyclosporine A  DED"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"dry eye disease  MedDRA"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "_":"Medical Dictionary for Regulatory Activities  NEI"}  {"#name":"keyword"  "$":{"id":"kwrd0075"}  "$$":[{"#name":"text"  "_":"National Eye Institute  OSDI"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"Ocular Surface Disease Index  QoL"}  {"#name":"keyword"  "$":{"id":"kwrd0095"}  "$$":[{"#name":"text"  "_":"quality of life  TEAE"}  {"#name":"keyword"  "$":{"id":"kwrd0105"}  "$$":[{"#name":"text"  "_":"treatment-emergent adverse event  VAS"}  {"#name":"keyword"  "$":{"id":"kwrd0115"}  "$$":[{"#name":"text"  "_":"visual analog scale
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号